Clinical Trials Directory

Trials / Suspended

SuspendedNCT03602040

A Psychoeducational Intervention Supporting Patients With an Inherited Cardiac Condition

A Psychoeducational Intervention Supporting Patients With a New Diagnosis and/or Genetic Carrier Status for an Inherited Cardiac Condition-a Feasibility Study

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
King's College London · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Inherited heart conditions (IHCs) can cause young sudden deaths due to a genetic trait that leads to a thickened heart muscle or abnormal heart rhythms. Relatives of an affected person have a 50% chance of inheriting IHCs and this is determined either through a blood test (predictive genetic test) and/or physical tests such as a heart tracing (electrocardiogram), scan (echocardiogram) and exercise test. When patients find out they are affected or are carriers for an IHC, they have numerous questions about medical management, prognosis, lifestyle; as well as experiencing stress and anxiety because of the impact on their health and risk to their family. Based on published studies and interviews, a psychoeducational intervention underpinned by Self-determination Theory was developed to support these patients An uncontrolled study to determine the feasibility of the intervention and outcome measures will be undertaken. Patients with a new IHC diagnosis or a carrier result aged 16 years and older will be recruited from outpatient clinics in London and will be receive the intervention consisting of a disease-specific information leaflet, a personalised lifestyle consideration guide and participation in a 1-hour group session facilitated by a cardiac genetic nurse. Outcome measures to look at degree of self-determination, autonomy support and competence; and heart-related anxiety will be collected at baseline and at 3 months post intervention. Clinical and socio-demographic data will be obtained from medical notes. The feasibility and acceptability of the intervention will be measured by assessment of the study procedures such as recruitment, retention and any adverse events. It is expected that there will be up to 4 consecutive group sessions and feedback from each session will be used to co-design and refine the intervention model for a definitive clinical trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPISICCPISICC consists of: 1. Standard disease-specific information leaflet 2. Personalised lifestyle consideration form 3. 1-hour group session with up to 10 participants facilitated by the PhD student who is also an experienced cardiac genetic nurse. This will include discussions of 2 scenarios (communicating with clinicians and communicating with family) and a question and answer session based on the personalised lifestyle consideration form Components a) and b) will be given to the patient after the baseline assessment and there will be an interval of 2 weeks before the participants attend for component c).

Timeline

Start date
2022-06-01
Primary completion
2023-06-01
Completion
2024-06-01
First posted
2018-07-26
Last updated
2021-02-25

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03602040. Inclusion in this directory is not an endorsement.